E‐cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models-Reference-Cited by-同舟云学术

E‐cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models

Published:2021-12-26 Issue: Volume: Page:
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Molecular Oncology

Author:

Bruun Jarle¹²,Eide Peter W.¹²,Bergsland Christian Holst¹²,Bruck Oscar³,Svindland Aud²⁴⁵,Arjama Mariliina⁶,Välimäki Katja⁶,Bjørnslett Merete¹²,Guren Marianne G.²⁷,Kallioniemi Olli⁶⁸,Nesbakken Arild²⁴⁹,Lothe Ragnhild A.¹²⁴^ORCID,Pellinen Teijo²⁶^ORCID

Affiliation:

1. Department of Molecular Oncology Institute for Cancer Research Oslo University Hospital Norway

2. K.G. Jebsen Colorectal Cancer Research Centre Division for Cancer Medicine Oslo University Hospital Norway

3. Hematology Research Unit Helsinki University of Helsinki and Comprehensive Cancer Center Helsinki University Hospital Finland

4. Institute for Clinical Medicine Faculty of Medicine University of Oslo Norway

5. Department of Pathology Oslo University Hospital Norway

6. Institute for Molecular Medicine Finland HiLIFE University of Helsinki Finland

7. Department of Oncology Oslo University Hospital Norway

8. Science for Life Laboratory Department of Oncology & Pathology Karolinska Institutet Stockholm Sweden

9. Department of Gastrointestinal Surgery Oslo University Hospital Norway

Funder

Kreftforeningen

Stiftelsen Kristian Gerhard Jebsen

Instrumentariumin Tiedesäätiö

Sigrid Juséliuksen Säätiö

Helse Sør-Øst RHF

Norges Forskningsråd

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13159

Reference51 articles.

1. A Perspective on Cancer Cell Metastasis

2. EMT and Cancer: More Than Meets the Eye

3. Molecular mechanisms of epithelial–mesenchymal transition

4. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications

5. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review and meta-analysis combined with bioinformatic analysis on the predictive value of E-cadherin in patients with renal cell carcinoma;Expert Review of Molecular Diagnostics;2024-08-26

2. Gene expression markers in peripheral blood and outcome in patients with platinum‐resistant ovarian cancer: A study of the European GANNET53 consortium;International Journal of Cancer;2024-04-27

3. Aberrant β-Catenin Expression and Its Association With Epithelial-Mesenchymal Transition and Clinical Outcomes of Colorectal Cancer;Cureus;2024-01-28

4. Signet ring-cell colorectal adenocarcinoma: review and clinical case;Meditsinskiy sovet = Medical Council;2024-01-18

5. Evaluating Recurrence Risk in Patients Undergoing Breast-conserving Surgery Using E-cadherin Staining as a Biomarker;In Vivo;2024